Főoldal / Kutatás / Jefferson Einstein Philadelphia Hospital Intézmény
Jefferson Einstein Philadelphia Hospital Más néven: Einstein Medical Center · Einstein Medical Center Philadelphia · The Jewish Hospital
21 futó vizsgálat 10 lezárt vizsgálat 8014 publikáció (OpenAlex) Futó vizsgálatok Toboroz
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
NCT07234968 · Thomas Jefferson University · Forrás
Fut, nem toboroz
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
NCT06538038 · PrECOG, LLC. · Forrás
Toboroz
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
NCT06308978 · 1. fázis · Fate Therapeutics · Forrás
Fut, nem toboroz
An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
NCT06117891 · Bayer · Forrás
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034 · 3. fázis · Janssen Research & Development, LLC · Forrás
Toboroz
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
NCT05677490 · 3. fázis · Alliance for Clinical Trials in Oncology · Forrás
Fut, nem toboroz
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
NCT05050084 · 3. fázis · NRG Oncology · Forrás
Fut, nem toboroz
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
NCT05064553 · Exact Sciences Corporation · Forrás
Fut, nem toboroz
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
NCT04513717 · 3. fázis · NRG Oncology · Forrás
Fut, nem toboroz
Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy
NCT03970343 · Impulse Dynamics · Forrás
Fut, nem toboroz
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
NCT07224347 · Anne Murray · Forrás
Fut, nem toboroz
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
NCT03108456 · Abbott Medical Devices · Forrás
Fut, nem toboroz
Breast Cancer WEight Loss Study (BWEL Study)
NCT02750826 · 3. fázis · Alliance for Clinical Trials in Oncology · Forrás
Fut, nem toboroz
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
NCT02488967 · 3. fázis · NRG Oncology · Forrás
Fut, nem toboroz
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
NCT02201992 · 3. fázis · ECOG-ACRIN Cancer Research Group · Forrás
Fut, nem toboroz
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
NCT02193282 · 3. fázis · National Cancer Institute (NCI) · Forrás
Fut, nem toboroz
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
NCT02194738 · National Cancer Institute (NCI) · Forrás
Fut, nem toboroz
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
NCT02115282 · 3. fázis · National Cancer Institute (NCI) · Forrás
Fut, nem toboroz
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
NCT01708954 · 2. fázis · National Cancer Institute (NCI) · Forrás
Fut, nem toboroz
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT00602641 · 3. fázis · National Cancer Institute (NCI) · Forrás
Fut, nem toboroz
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
NCT00098475 · 3. fázis · National Cancer Institute (NCI) · Forrás
Egyszerre toboroz Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Regiszterbeli névváltozatok (5) Mind mutatása Elrejtés A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.
Einstein Medical Center Philadelphia
Philadelphia, Pennsylvania 19141
18 vizsgálat
Einstein Medical Center
Philadelphia, Pennsylvania 19141
10 vizsgálat
Jefferson Einstein Hospital Philadelphia
Philadelphia, Pennsylvania 19141
1 vizsgálat
Jefferson Einstein Philadelphia Hospital
Philadelphia, Pennsylvania 19141
1 vizsgálat
Jefferson Einstein Philadelphia Hospital - Neurology
Philadelphia, Pennsylvania 19141
1 vizsgálat
Betegségek Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.
Hibát jelzek